Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Vodori is raising $4,000,000.00 in new funding. Sources indicate as part of senior management President, Scott Rovegno played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vodori

Vodori is an innovative technology company creating cloud-based software that revolutionizes how life science companies (such as Acacia Pharma, Pentax Medical, and Tris Pharma) move regulated content from ideation through review, approval, and distribution. Customers love our unparalleled product design and usability, decades of industry knowledge, and world-class customer service a combination you won’t get anywhere else.

To learn more about Vodori, visit http://www.vodori.com/

Contact:
Scott Rovegno, President
312-324-3992
scott.rovegno@vodori.com
https://www.linkedin.com/in/scottrovegno/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved